Anaerobic bacteria in oral infections.
D000190:Actinomyces / Q000302:isolation & purification; D000539:Alveolar Process / Q000382:microbiology; D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D001439:Bacteroides / Q000302:isolation & purification; D003470:Culture Media; D004352:Drug Resistance, Microbial; D005673:Fusobacterium / Q000302:isolation & purification; D007778:Lactobacillus / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D010462:Peptostreptococcus / Q000302:isolation & purification; D010482:Periapical Abscess / Q000209:etiology / Q000382:microbiology*; D013291:Streptococcus / Q000302:isolation & purification; D013492:Suppuration / Q000382:microbiology
D000900:Anti-Bacterial Agents; D003470:Culture Media